Inventor · disambiguated record
Gavin Alistair Whitlock
Also filed as: WHITLOCK GAVIN A · WHITLOCK GAVIN ALISTAIR · WHITLOCK Gavin
35 granted patents·12 pending applications·365 citations·filing 1998–2025
97Inventor score
Files withMISSION THERAPEUTICS LTD13PFIZER11IP2IPO INNOVATIONS LTD4ACCENT THERAPEUTICS INC3ANACOR PHARMACEUTICALS INC2
Top patents by PatentIndex Score
47 records- 0195US6511993B1Metalloprotease inhibitorsFiled 2000·Granted Jan 28, 2003·84 cites·38 claims
- 0294US9926307B2CompoundsMISSION THERAPEUTICS LTD·Filed 2015·Granted Mar 27, 2018·14 cites·16 claims
- 0394US8895544B2IndazolesPFIZER LTD·Filed 2013·Granted Nov 25, 2014·43 cites·18 claims
- 0493US10343992B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2016·Granted Jul 9, 2019·7 cites·2 claims
- 0592US10689345B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2019·Granted Jun 23, 2020·4 cites·14 claims
- 0692US8575336B2IndazolesCOE JOTHAM WADSWORTH·Filed 2012·Granted Nov 5, 2013·41 cites·13 claims
- 0792US7378436B2CompoundsPFIZER·Filed 2004·Granted May 27, 2008·50 cites·13 claims
- 0889US10392380B2CompoundsMISSION THERAPEUTICS LTD·Filed 2018·Granted Aug 27, 2019·6 cites·17 claims
- 0988US9518052B2Pyrazolopyridines and pyrazolopyrimidinesPFIZER·Filed 2015·Granted Dec 13, 2016·8 cites·12 claims
- 1087US10774078B2CompoundsMISSION THERAPEUTICS LTD·Filed 2019·Granted Sep 15, 2020·2 cites·10 claims
- 1186US11472798B2CompoundsMISSION THERAPEUTICS LTD·Filed 2020·Granted Oct 18, 2022·1 cites·11 claims
- 1285US12233065B2Inhibitors of RNA helicase DHX9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·0 cites·16 claims
- 1385US10640498B2CompoundsMISSION THERAPEUTICS LTD·Filed 2017·Granted May 5, 2020·6 cites·17 claims
- 1483US11390584B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2020·Granted Jul 19, 2022·1 cites·14 claims
- 1583US7122683B2Amides useful as monoamine re-uptake inhibitorsPFIZER·Filed 2005·Granted Oct 17, 2006·4 cites·12 claims
- 1682US12162867B2Inhibitors of RNA helicase DHX9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·0 cites·16 claims
- 1781US11993595B2CompoundsMISSION THERAPEUTICS LTD·Filed 2022·Granted May 28, 2024·0 cites·10 claims
- 1881US10022376B2Pyrazolopyridines and pyrazolopyrimidinesPFIZER·Filed 2016·Granted Jul 17, 2018·3 cites·9 claims
- 1980US11945799B24-ethynylpyridine derivatives useful as GCN2 inhibitorsIP2IPO INNOVATIONS LTD·Filed 2023·Granted Apr 2, 2024·0 cites·5 claims
- 2080US2025145597A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2179US6495568B1Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitorsWARNER LAMBERT CO·Filed 1998·Granted Dec 17, 2002·46 cites·16 claims
- 2278US2022251041A11-cyano-pyrrolidine compounds as usp30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2373US9533989B2Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitorsZIARCO PHARMA LTD·Filed 2013·Granted Jan 3, 2017·2 cites·8 claims
- 2472US10961261B2Oxaborole analogs and uses thereofANACOR PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·1 cites·20 claims
- 2572US10683269B22-cyanoisoindoline derivatives for treating cancerMISSION THERAPEUTICS LTD·Filed 2017·Granted Jun 16, 2020·1 cites·15 claims
- 2671US6090852ASubstituted alpha-aminosulphonyl-acetohydroxamic acids as therapeutic agentsPFIZER·Filed 1999·Granted Jul 18, 2000·31 cites·21 claims
- 2770US11066365B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2019·Granted Jul 20, 2021·0 cites·14 claims
- 2870US11053198B21-cyano-pyrrolidine compounds as USP30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2019·Granted Jul 6, 2021·0 cites·4 claims
- 2968US11691992B2Oxaborole analogs and uses thereofANACOR PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·20 claims
- 3068US6645993B23-heterocyclylpropanohydroxamic acid PCP inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Nov 11, 2003·4 cites·15 claims
- 3168US2024409530A1Disubstituted Pyrimidine Compounds for Ketohexokinase InhibitionCENTENNIAL THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3267US2025340530A1GCN2 INHIBITOR (as amended)IP2IPO INNOVATIONS LTD·Filed 2023·Application pending·0 cites
- 3366US7928099B2Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonistsPFIZER·Filed 2008·Granted Apr 19, 2011·1 cites·11 claims
- 3464US2023271939A14-ethynylpyridine derivatives useful as gcn2 inhibitorsIP2IPO INNOVATIONS LTD·Filed 2021·Application pending·0 cites
- 3563US12459952B2TREM2 modulatorsMUNA THERAPEUTICS APS·Filed 2025·Granted Nov 4, 2025·0 cites·17 claims
- 3663US2025129068A14-(2-pyrazolo[3,4-b]pyridine-5-yl)ethynyl-2-pyridine derivatives useful as gcn2 inhibitorsIP2IPO INNOVATIONS LTD·Filed 2022·Application pending·0 cites
- 3761US6831088B23-heterocyclypropanohydroxamic acid PCP inhibitorsPFIZER·Filed 2003·Granted Dec 14, 2004·2 cites·17 claims
- 3861US6716861B23-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitorsPFIZER·Filed 2001·Granted Apr 6, 2004·2 cites·17 claims
- 3958US2008161309A1Novel CompoundsFISH PAUL VINCENT·Filed 2008·Application pending·0 cites
- 4058US2025345446A1Bifunctional molecules that selectively induce degradation of extracellular targets in lysosomesDRAUPNIR BIO APS·Filed 2023·Application pending·0 cites
- 4157US7214694B23-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitorsPFIZER·Filed 2003·Granted May 8, 2007·1 cites·9 claims
- 4256US2008306123A1Novel compoundsPFIZER·Filed 2008·Application pending·0 cites
- 4352US2005250775A1Novel compoundsFISH PAUL V·Filed 2005·Application pending·0 cites
- 4447US10065964B2Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitorsZIARCO PHARMA LTD·Filed 2016·Granted Sep 4, 2018·0 cites·19 claims
- 4546US2010137316A1Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use ThereofFISH PAUL VINCENT·Filed 2010·Application pending·0 cites
- 4641US2007105870A1Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitorsPFIZER·Filed 2005·Application pending·0 cites
- 4739US12459953B2TREM2 modulatorsMUNA THERAPEUTICS APS·Filed 2025·Granted Nov 4, 2025·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Gavin Alistair Whitlock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →